SuRo Capital (SSSS) Q4 2025 earnings review
Q4 NAV Stumbles, But Projected 2026 Surge Steals the Spotlight
SuRo Capital's Q4 results presented a stark dichotomy. On paper, Net Asset Value (NAV) retreated sequentially by 12% to $8.09 per share, driven by a sudden $21.3 million unrealized depreciation hit. However, management completely overshadowed this sequential reversal by announcing that pending 2026 portfolio financings are expected to add a massive $5.00 to $6.50 to NAV per share. If these deals close, NAV would instantly surge past $13, radically altering the valuation picture. Meanwhile, the firm's monetization engine remains stable, generating $6.8 million in Q4 net realized gains to fund ongoing dividends and debt repurchases.
🐂 Bull Case
The projected $5.00-$6.50 per share accretion represents an implied ~71% sequential NAV explosion. SuRo's early bets on category-defining private companies appear poised for dramatic upward revaluations.
The firm successfully monetized legacy holdings (CW Opportunity 2 LP, Forge Global) for $12.2 million in Q4 gross proceeds, sustaining its $0.25 quarterly dividend capacity and funding aggressive debt repurchases.
🐻 Bear Case
Before the 2026 promises, the actual Q4 performance was weak. The $21.3 million unrealized depreciation erased a significant portion of the gains generated earlier in the year, highlighting the volatility of private marks.
The top five investments now account for 54.3% of the entire portfolio. OpenAI alone represents nearly 19% of the fund. Any misstep in these specific names will severely damage SuRo's equity value.
⚖️ Verdict: 🟢
Bullish, but highly conditional. The 2026 guidance is a game-changer that makes the Q4 NAV dip look like a minor speed bump. However, because this accretion relies entirely on private financings that haven't officially closed, investors are underwriting significant execution risk.
Key Themes
The 2026 Mega-Catalyst
Management dropped a bombshell by guiding that 'recent 2026 portfolio company financings' will add an estimated $5.00 to $6.50 per share to NAV. Given the portfolio composition, this is almost certainly driven by hyper-growth AI holdings like OpenAI (ARK Type One) or Canva, which were previously reported to be exploring massive secondary valuations. This expected markup completely changes the firm's baseline valuation.
Q4 Unrealized Valuation Reversal
While 2026 looks bright, Q4 2025 was a stark reversal. Net change in unrealized depreciation was $(21.3) million, directly causing the $1.14 per share drop in NAV. Management did not specify which assets were written down in the release, but this indicates that outside of the headline AI winners, other parts of the portfolio are facing significant multiple compression or fundamental weakness.
Portfolio Concentration Escales
SuRo's concentration risk is accelerating. The top five investments now make up 54.3% of the portfolio (up from 52% in Q3). The ARK Type One Deep Ventures Fund (OpenAI) position grew to $42.2 million (18.7% of total portfolio). This transforms SuRo from a diversified venture fund into a highly concentrated proxy for a handful of late-stage tech darlings.
Expanding AI Compute Footprint with TensorWave
SuRo continues to double down on its AI infrastructure thesis. In late 2025, they committed up to $20.0 million to Magnetar Opportunity 2025-4 LP (an SPV for TensorWave), funding the first $5.0 million in January 2026. By backing TensorWave—which utilizes AMD accelerators—SuRo is diversifying its hardware exposure beyond its existing NVIDIA-centric (CoreWeave) bets.
Active Monetization Funds Capital Returns
The monetization engine remains stable. SuRo realized $6.7 million in gains from CW Opportunity 2 LP (CoreWeave) and fully exited its Forge Global public shares in Q4. This liquidity allowed the firm to declare another $0.25 quarterly dividend and aggressively repurchase an additional 153,513 units of its 6.00% Notes due 2026, strengthening the balance sheet.
Financing Execution Risk in Current Macro
Management explicitly stated that the $5.00-$6.50 NAV bump relies on indications available today 'assuming each of the financings closes.' In the current volatile macro environment where late-stage venture deals can fall apart or re-trade during final diligence, booking this implied value ahead of actual closure carries material risk.
Other KPIs
Decelerating slightly from $58.3 million at the end of Q3 2025. This consists of cash and freely tradable public securities. Despite the drop, it remains more than sufficient to cover near-term operational needs and the targeted deployment into the TensorWave SPV.
Operating loss widened slightly from $(14.0) million in FY 2024. Total operating expenses for the year were $18.2 million against just $1.7 million in investment income. The firm relies entirely on realizing capital gains from its portfolio to generate net income, making liquidity events crucial.
Guidance
Accelerating. This is a staggering forecast. Added to the Q4 baseline NAV of $8.09, the midpoint ($5.75) implies an imminent NAV of ~$13.84—a massive 71% sequential leap. If achieved, this will mark the highest NAV for the firm since 2021.
Stable deployment pipeline. SuRo has $15.0 million in unfunded commitments remaining for this AI infrastructure play, subject to certain closing conditions, ensuring continued capital deployment into their highest-conviction theme in Q1/Q2 2026.
Key Questions
Drivers of the Q4 Write-down
NAV dropped by over $1.00 per share due to unrealized depreciation in Q4. Which specific portfolio companies drove this $21.3 million mark-down, and does it reflect fundamental deterioration or just broader market multiple compression?
Certainty of the 2026 Mega-Markups
You guided to a $5.00-$6.50 per share NAV increase based on pending 2026 financings. How legally binding are these financing rounds currently, and are there any regulatory or macro hurdles that could derail them before closing?
Managing OpenAI Concentration
The ARK Type One fund (OpenAI) now represents nearly 19% of the portfolio. If the pending 2026 financings drive this valuation even higher, OpenAI could easily exceed 30% of your total assets. What is the board's strategy for managing this extreme single-asset concentration risk?
Pacing of CoreWeave Monetization
With the sale of CW Opportunity 2 LP stakes generating the bulk of your realized gains this quarter, what is the anticipated cadence for monetizing the remainder of this position throughout 2026?